Clinical Trial Update: A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a new treatment for allergic conjunctivitis has been withdrawn. The sponsor indicates the study will not proceed under this …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• New Treatment for Allergic Conjunctivitis

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 2 | Status: WITHDRAWN